Search details
1.
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata.
J Am Acad Dermatol
; 89(5): 911-919, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37019385
Results
1 -
1
de 1
1
Next >
>>